Literature DB >> 2126208

Acylation of L-asparaginase with total retention of enzymatic activity.

M B Martins1, J C Jorge, M E Cruz.   

Abstract

Acylation of L-asparaginase (L-asparagine amidohydrolase, EC 3.5.1.1) with complete retention of catalytic activity was achieved. Several parameters of the acylation method, based on the binding of palmitoyl residues to epsilon-NH2 groups of protein, were optimized. The correlation between the acylation degree of L-asparaginase and the retention of catalytic activity was established. For a palmitoyl chloride/protein molar ratio ranging from 50 to 900, a degree of modification of 10 to 30% and a retention of catalytic activity of 98 to 60% respectively, was observed. Hydrophobicity of 30% acylated protein was correlated with turbidity in water and octanol and was compared with the native protein. Acylated protein incorporated into liposomes, showed an increase in catalytic activity in intact form as compared to the native enzyme. By the introduction of a sequential acylation cycle, an improvement of the degree of modification with a maximal value at 50% was obtained. Total retention of catalytic activity was achieved by acylation in the presence of 8 mM L-asparagine in a reactional medium.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126208     DOI: 10.1016/0300-9084(90)90050-q

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  3 in total

1.  Liposomal palmitoyl-L-asparaginase: characterization and biological activity.

Authors:  J C Jorge; R Perez-Soler; J G Morais; M E Cruz
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Superoxide dismutase enzymosomes: carrier capacity optimization, in vivo behaviour and therapeutic activity.

Authors:  M Luísa Corvo; H Susana Marinho; Paulo Marcelino; Rui M Lopes; Carlos A Vale; Claúdia R Marques; Luísa C D Martins; Peter Laverman; Gert Storm; M Bárbara A F Martins
Journal:  Pharm Res       Date:  2014-07-19       Impact factor: 4.200

Review 3.  Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

Authors:  S Kim
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.